These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21642244)

  • 1. Gender and mortality following hospitalisation for COPD.
    Fahim A; Lee WY; Faruqi S; Kastelik JA
    Thorax; 2011 Nov; 66(11):1009; author reply 1009. PubMed ID: 21642244
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals.
    Walker PP; Thompson E; Crone H; Flatt G; Holton K; Hill SL; Pearson MG
    Thorax; 2013 Oct; 68(10):968-70. PubMed ID: 23788585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in survival following hospitalisation for COPD.
    Gonzalez AV; Suissa S; Ernst P
    Thorax; 2011 Jan; 66(1):38-42. PubMed ID: 21113016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.
    Schmier JK; Halpern MT; Jones ML
    Drugs Aging; 2005; 22(9):717-29. PubMed ID: 16156676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung function impairment, COPD hospitalisations and subsequent mortality.
    Garcia-Aymerich J; Serra Pons I; Mannino DM; Maas AK; Miller DP; Davis KJ
    Thorax; 2011 Jul; 66(7):585-90. PubMed ID: 21515553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
    Lindberg A; Lundbäck B
    Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
    Mannino DM; Sonia Buist A; Vollmer WM
    Thorax; 2007 Mar; 62(3):237-41. PubMed ID: 17090573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic and operational burden associated with malnutrition in chronic obstructive pulmonary disease.
    Hoong JM; Ferguson M; Hukins C; Collins PF
    Clin Nutr; 2017 Aug; 36(4):1105-1109. PubMed ID: 27496063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease in Denmark: Age-period-cohort analysis of first-time hospitalisations and deaths 1994-2012.
    Lykkegaard J; Kristensen GN
    Respir Med; 2016 May; 114():78-83. PubMed ID: 27109815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential misclassification of causes of death from COPD.
    Jensen HH; Godtfredsen NS; Lange P; Vestbo J
    Eur Respir J; 2006 Oct; 28(4):781-5. PubMed ID: 16807258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent improvement in long-term survival after a COPD hospitalisation.
    Almagro P; Salvadó M; Garcia-Vidal C; Rodriguez-Carballeira M; Delgado M; Barreiro B; Heredia JL; Soriano JB
    Thorax; 2010 Apr; 65(4):298-302. PubMed ID: 20388752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality.
    Jairam PM; van der Graaf Y; Lammers JW; Mali WP; de Jong PA;
    Thorax; 2015 Aug; 70(8):725-31. PubMed ID: 26024687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mortality due to chronic obstructive pulmonary disease: indicators of impact, access to health services, and outcome of hospital treatment in an Italian region].
    Faustini A; Marino C; Dovidio M; Perucci CA
    Epidemiol Prev; 2007; 31(2-3):140-7. PubMed ID: 18677863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
    Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
    Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
    Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in mortality due to chronic obstructive pulmonary disease (COPD) in Mexico, 1980-2002.
    Tovar Guzmán VJ; López Antuñano FJ; Rodríguez Salgado N
    Arch Med Res; 2005; 36(1):65-9. PubMed ID: 15777998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the mortality of chronic obstructive pulmonary disease in Taiwan, 1981-2002.
    Kuo LC; Yang PC; Kuo SH
    J Formos Med Assoc; 2005 Feb; 104(2):89-93. PubMed ID: 15765162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mortality trend on chronic obstructive pulmonary disease in Liaoning province, 1984-2010].
    Yu LZ; Feng YP; Mu HJ; Liu L; Yu LY; Li YX; Zhang SJ; Pan GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Apr; 33(4):399-403. PubMed ID: 22781414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising total costs and mortality rates associated with admissions due to COPD exacerbations.
    Molinari N; Chanez P; Roche N; Ahmed E; Vachier I; Bourdin A
    Respir Res; 2016 Nov; 17(1):149. PubMed ID: 27842545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.